Correction: Döring et al. Discovery of Novel Symmetrical 1,4-Dihydropyridines as Inhibitors of Multidrug-Resistant Protein (MRP4) Efflux Pump for Anticancer Therapy. Molecules 2021, 26, 18

Detalles Bibliográficos
Autores principales: Döring, Henry, Kreutzer, David, Ritter, Christoph, Hilgeroth, Andreas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Correction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9181869/
https://www.ncbi.nlm.nih.gov/pubmed/35684585
http://dx.doi.org/10.3390/molecules27113575
_version_ 1784723891185254400
author Döring, Henry
Kreutzer, David
Ritter, Christoph
Hilgeroth, Andreas
author_facet Döring, Henry
Kreutzer, David
Ritter, Christoph
Hilgeroth, Andreas
author_sort Döring, Henry
collection PubMed
description
format Online
Article
Text
id pubmed-9181869
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-91818692022-06-10 Correction: Döring et al. Discovery of Novel Symmetrical 1,4-Dihydropyridines as Inhibitors of Multidrug-Resistant Protein (MRP4) Efflux Pump for Anticancer Therapy. Molecules 2021, 26, 18 Döring, Henry Kreutzer, David Ritter, Christoph Hilgeroth, Andreas Molecules Correction MDPI 2022-06-02 /pmc/articles/PMC9181869/ /pubmed/35684585 http://dx.doi.org/10.3390/molecules27113575 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Correction
Döring, Henry
Kreutzer, David
Ritter, Christoph
Hilgeroth, Andreas
Correction: Döring et al. Discovery of Novel Symmetrical 1,4-Dihydropyridines as Inhibitors of Multidrug-Resistant Protein (MRP4) Efflux Pump for Anticancer Therapy. Molecules 2021, 26, 18
title Correction: Döring et al. Discovery of Novel Symmetrical 1,4-Dihydropyridines as Inhibitors of Multidrug-Resistant Protein (MRP4) Efflux Pump for Anticancer Therapy. Molecules 2021, 26, 18
title_full Correction: Döring et al. Discovery of Novel Symmetrical 1,4-Dihydropyridines as Inhibitors of Multidrug-Resistant Protein (MRP4) Efflux Pump for Anticancer Therapy. Molecules 2021, 26, 18
title_fullStr Correction: Döring et al. Discovery of Novel Symmetrical 1,4-Dihydropyridines as Inhibitors of Multidrug-Resistant Protein (MRP4) Efflux Pump for Anticancer Therapy. Molecules 2021, 26, 18
title_full_unstemmed Correction: Döring et al. Discovery of Novel Symmetrical 1,4-Dihydropyridines as Inhibitors of Multidrug-Resistant Protein (MRP4) Efflux Pump for Anticancer Therapy. Molecules 2021, 26, 18
title_short Correction: Döring et al. Discovery of Novel Symmetrical 1,4-Dihydropyridines as Inhibitors of Multidrug-Resistant Protein (MRP4) Efflux Pump for Anticancer Therapy. Molecules 2021, 26, 18
title_sort correction: döring et al. discovery of novel symmetrical 1,4-dihydropyridines as inhibitors of multidrug-resistant protein (mrp4) efflux pump for anticancer therapy. molecules 2021, 26, 18
topic Correction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9181869/
https://www.ncbi.nlm.nih.gov/pubmed/35684585
http://dx.doi.org/10.3390/molecules27113575
work_keys_str_mv AT doringhenry correctiondoringetaldiscoveryofnovelsymmetrical14dihydropyridinesasinhibitorsofmultidrugresistantproteinmrp4effluxpumpforanticancertherapymolecules20212618
AT kreutzerdavid correctiondoringetaldiscoveryofnovelsymmetrical14dihydropyridinesasinhibitorsofmultidrugresistantproteinmrp4effluxpumpforanticancertherapymolecules20212618
AT ritterchristoph correctiondoringetaldiscoveryofnovelsymmetrical14dihydropyridinesasinhibitorsofmultidrugresistantproteinmrp4effluxpumpforanticancertherapymolecules20212618
AT hilgerothandreas correctiondoringetaldiscoveryofnovelsymmetrical14dihydropyridinesasinhibitorsofmultidrugresistantproteinmrp4effluxpumpforanticancertherapymolecules20212618

Ejemplares similares